Derivative Instruments

9 Months Ended

Sep. 26, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Foreign Currency Exchange Forward Contracts

The Company transacts business in various foreign currencies, has international sales, cost of sales, and expenses denominated in foreign currencies, and carries foreign-currency-denominated monetary assets and liabilities, subjecting the Company to foreign currency risk. The Company’s primary foreign currency risk management objective is to protect the U.S. dollar value of future cash flows. The Company utilizes foreign currency forward contracts, which are primarily short term in nature.

Historically, the Company enters into foreign currency exchange forward contracts to manage its exposure to fluctuation in foreign exchange rates that arise from its euro denominated receivables and restricted cash balances. Gains and losses on these contracts are intended to offset the impact of foreign exchange rate fluctuations on the underlying foreign currency denominated accounts receivables and restricted cash and therefore, do not subject the Company to material balance sheet risk.

As of September 26, 2020, and December 28, 2019, the Company posted collateral of $0.9 million and $0.9 million, respectively, on its derivative instruments to cover potential credit risk exposure. This amount is classified as other long-term restricted cash on the accompanying condensed consolidated balance sheets.

For the three months ended September 26, 2020 and September 28, 2019, the before-tax effect of the foreign currency exchange forward contracts was a net gain of insignificant amount for both periods and for the nine months ended September 26, 2020 and September 28, 2019, the before-tax effect of the foreign currency exchange forward contracts was a net gain of $0.2 million and $1.2 million, respectively, included in other gain (loss), net in the condensed consolidated statements of operations. In each of these periods, the impact of the gross gains and losses was offset by foreign exchange rate fluctuations on the underlying foreign currency denominated amounts.

As of September 26, 2020, the Company did not designate foreign currency exchange forward contracts as hedges for accounting purposes. Accordingly, changes in the fair value are recorded in the accompanying condensed consolidated statements of operations. These contracts were entered into with one high-quality institution and the Company consistently monitors the creditworthiness of the counterparties.

The fair value of derivative instruments not designated as hedging instruments in the Company’s condensed consolidated balance sheets was as follows (in thousands):


	As of September 26, 2020		As of December 28, 2019
	Gross Notional(1)		Prepaid expenses and other current assets		Gross Notional(1)		Other Accrued Liabilities
Foreign currency exchange forward contracts
Related to euro denominated receivables	$	632	$	3	$	27,566	$	(159)
	$	632	$	3	$	27,566	$	(159)

(1)Represents the face amounts of forward contracts that were outstanding as of the end of the period noted.

Accounts Receivable Factoring

The Company sells certain designated trade account receivables based on factoring arrangements to a large international banking institution. Pursuant to the terms of the arrangements, the Company accounts for these transactions in accordance with ASC Topic 860, "Transfers and Servicing". The Company's factor purchases trade accounts receivables on a non-recourse basis and without any further obligations. Trade accounts receivables balances sold are removed from the condensed consolidated balance sheets and cash received is reflected as cash provided by operating activities in the condensed consolidated statements of cash flow. The difference between the fair value of the Company's trade receivables and the proceeds received is recorded as interest expense in the Company's condensed consolidated statements of operations. For the three and nine months ended September 26, 2020, the Company's recognized factoring related interest expense was approximately $0.1 million and $0.3 million, respectively, and for the three and nine months ended September 28, 2019 was approximately $0.1 million and $0.5 million, respectively. For the three and nine months ended September 26, 2020, the Company's gross amount of trade accounts receivables sold was approximately $16.3 million and $61.6 million, respectively, and for the three and nine months ended September 28, 2019 was approximately $17.2 million and $62.8 million, respectively.